Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16028948 | 0.85 | LMNA (0.46) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL20738800 | 0.83 | TSHR (0.37) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| SCHEMBL2488500 | 0.81 | ALDH1A1 (0.54) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL1784668 | 0.80 | LMNA (0.36) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| SCHEMBL21510518 | 0.80 | ALDH1A1 (0.37) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| SCHEMBL2871005 | 0.79 | — | — | |
| SCHEMBL31051710 | 0.77 | TSHR (0.36) | TSHRALDH1A1 | |
| SCHEMBL15541114 | 0.77 | PDK2 (0.33) | PMP22KMT2APDK2 | |
| SCHEMBL24107357 | 0.77 | FFAR3 (0.39) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| SCHEMBL8733632 | 0.77 | LMNA (0.33) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113874426-B | Water-soluble film and package | 株式会社可乐丽 | 2025-03-28 | — | — | CN | claimed |
| US-20250333902-A1 | FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250276924-A1 | CHEMICAL AND BIOLOGICAL DEGRADATION OF ETHER PER- AND POLYFLUOROALKYL SUBSTANCES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-04 | — | — | US | disclosed |
| CN-113874426-B | Water-soluble film and package | 株式会社可乐丽 | 2025-03-28 | — | — | CN | disclosed |
| EP-4516773-A1 | FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-03-05 | — | — | EP | disclosed |
| WO-2024185687-A1 | FLUORINE-CONTAINING COMPOUND | ダイキン工業株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2023180189-A1 | MPRO TARGETING ANTIVIRAL COMPOUNDS | EXSCIENTIA AI LIMITED (GB) | 2023-09-28 | — | — | WO | disclosed |
| WO-2022272036-A1 | TEAD INHIBITORS AND USES THEREOF | CEDILLA THERAPEUTICS, INC. (US) | 2022-12-29 | — | — | WO | disclosed |
| CN-113874426-A | Water-soluble film and package | 株式会社可乐丽 | 2021-12-31 | — | — | CN | disclosed |
| WO-2020218321-A1 | WATER-SOLUBLE FILM AND PACKAGING | 株式会社クラレ | 2020-10-29 | — | — | WO | disclosed |
| EP-3624797-A1 | KINASE INHIBITORS AND USES THEREOF | Denali Therapeutics Inc. (US) | 2020-03-25 | — | — | EP | disclosed |
| WO-2018213632-A1 | KINASE INHIBITORS AND USES THEREOF | DENALI THERAPEUTICS INC. (US) | 2018-11-22 | — | — | WO | disclosed |
| CN-108699106-A | Novel trifluoromethyl propanamide derivative as HTRA1 inhibitor | 豪夫迈·罗氏有限公司 | 2018-10-23 | — | — | CN | disclosed |
| EP-1549705-B1 | FLUOROPOLYMER COMPOSITIONS | 3M INNOVATIVE PROPERTIES CO (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1549705-A1 | FLUOROPOLYMER COMPOSITIONS | 3M Innovative Properties Company (US) | 2005-07-06 | — | — | EP | disclosed |
| US-6846880-B2 | Composition comprising fluoropolymer including interpolymerized units derived from nitrogen-containing cure site monomer and amidine-containing curative, which is bis-amidine, tris-amidine, or tetra-amidine, or salt | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-01-25 | — | — | US | disclosed |
| WO-2004033546-A1 | FLUOROPOLYMER COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-04-22 | — | — | WO | disclosed |
| US-20040072959-A1 | Crosslinked elastomers using organonitrogen curing agents based on bis-amidine, tris-amidine, or tetra-amidine, or a salt thereof | 3M INNOVATIVE PROPERTIES COMPANY | 2004-04-15 | — | — | US | disclosed |
| CN-1309655-A | Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process | MERCK PATENT GMBH (DE) | 2001-08-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250276924-A1 | CHEMICAL AND BIOLOGICAL DEGRADATION OF ETHER PER- AND POLYFLUOROALKYL SUBSTANCES | PFAS, FGB, PFKFB1 | LMNA 3630/4885EGLN1 456/4885ALKBH5 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.